Delivery Order SPE2DB20D3303-SPE2DB24FY6M2
Award Date 1/3/24
Potential Completion Date 1/4/24
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product REXULTI 0.5 MG TABLET 30S. The order has a completion date of March 8, 2024 and a potential value of $4,592.77. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of a pharmaceutical product, REXULTI 1 MG TABLET 30S, with a potential value of $9,584.37 and a completion date of January 18, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and related distribution services to U.S. government agencies, primarily the...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $6,296.68 for the supply of REXULTI 0.5 MG TABLET 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $13,652.36, is for the delivery of REXULTI 4 MG TABLET 30S, a pharmaceutical product, with a period of performance through April 15, 2024. This delivery order is part of a larger indefinite...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $6,465.39 by the Defense Logistics Agency (DLA) to provide REXULTI 4 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of March 8, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA that has a potential value of up to $999,999,999.00 and a period of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the prime contractor, to provide REXULTI 1 MG TABLET 30S, a pharmaceutical product, with a potential value of $1,793.44. The award has a completion date of February 22, 2024. AmerisourceBergen Drug Corp is a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. This delivery order is part of a larger...
- This $5,627.36 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The award is for the supply of REXULTI 3 MG TABLET 30S, a brand name pharmaceutical product, with a completion date of February 16, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, as the...
- This $36,630.61 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award covers the delivery of the pharmaceutical product REXULTI 1 MG TABLET 30S, with a performance period through January 21, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $30,807.50 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 30-count bottles of 1 mg REXULTI tablets. Performance will take place in Conshohocken, Pennsylvania under a single-day period from July 25-26, 2023. As the prime contractor, Amerisourcebergen will fulfill the Defense Logistics Agency's requirement for this atypical antipsychotic...
- This $11,647.22 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product REXULTI 2 MG TABLET 30S. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holding several Indefinite Delivery Contracts (IDCs) with agencies such as the DLA and Department of Justice...